Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate

HY-17371-100mg Oxaliplatin [61825-94-3] Hexabiogen

Capecitabine, C15H22FN3O6

Structures and mode of action of antimetabolites and DHFR inhibitors.

Full article: Facile construction of dual-drug loaded nanoparticles for improvement synergistic chemotherapy in prostate cancer

Mechanism of action of capecitabine upon conversion into active 5-FU.

Tysinor 150 Mg Capecitabine USP

Cells, Free Full-Text

Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response

A simplified map of 5-fluorouracil and capecitabine metabolism and

Capecitabine-d11 (CAS Number: 1132662-08-8)

How Do Antibiotics Affect Nucleic Acid Synthesis?, Biomol Blog, Resources

Biomedicines, Free Full-Text

Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil